KIDSOrthoPediatrics Corp.

$24.49+37% 1Y

Is the price fair?

What KIDS's price assumes

OrthoPediatrics Corp. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.83× revenue.

1.83

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
1.34

Price / book · as of 2026-Q2

EV / sales
2.05

EV / sales

Details›
Price / bookas of 2026-Q2
1.34
EV / EBIToperating margin −12%: the multiple describes the denominator
not meaningful
EV / salesas of 2026-Q2
2.05
Market capitalisation26.1 million shares, counted Aug 4, 2026
$639M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.